Quantifying anti-trypanosomal treatment effects in chronic indeterminate Chagas disease: a secondary analysis of individual patient data from two proof-of-concept trials — James A Watson (2025) | RDL Network
Quantifying anti-trypanosomal treatment effects in chronic indeterminate Chagas disease: a secondary analysis of individual patient data from two proof-of-concept trials
James A Watson, Cintia Cruz, Fabiana Barreira, C. Forsyth, Alejandro G. Schijman, Rhys Peploe, Frauke Assmus, Caitlin Naylor, Jennifer Lee, Somya Mehra, Joel Tärning, Faustino Torrico, Joaquím Gascón, Lourdes Ortiz, Isabela Ribeiro, Sergio Sosa‐Estáni, Craig Tipple, Stéphane Hugonnet, Philippe J. Guérin, Laurent Fraisse, María‐Jesús Pinazo, Sir Nicholas White
Robert J. Commons, Megha Rajasekhar, Peta Edler, Tesfay Abreha, Ghulam Rahim Awab, J. Kevin Baird, Bridget E. Barber, Cindy S. Chu, Liwang Cui, André Daher, Lilia González-Cerón, Matthew J. Grigg, Jimee Hwang, Harin Karunajeewa, Marcus Lacerda, Simone Ladeia-Andrade, Kartini Lidia, Alejandro Llanos‐Cuentas, Rhea J. Longley, Dhélio B. Pereira, Ayodhia Pitaloka Pasaribu,
Mark A. Hlatky, Derek Boothroyd, Dena M Bravata, Eric Boersma, Jean Booth, Maria M. Brooks, Didier Carrié, Tim Clayton, Nicolas Danchin, Marcus Flather, Christian W. Hamm, Whady Hueb, Jan Kähler, Sheryl F. Kelsey, Spencer B. King, Andrzej S. Kosinski, Neuza Lopes, Kathryn M McDonald, Alfredo Santana, Patrick W. Serruys, Ulrich Sigwart,
Maayan Konigstein, Björn Redfors, Zixuan Zhang, Lak N. Kotinkaduwa, Gary S. Mintz, Pieter C. Smits, Patrick W. Serruys, Clemens von Birgelen, Mahesh V. Madhavan, Mordechai Golomb, Ori Ben‐Yehuda, Roxana Mehran, Martin B. Leon, Gregg W. Stone
Discussion(0)
No comments yet. Be the first to comment.